| X | ||||||||||
- Definition The amount of technical milestone payment to be paid per tranche as the first component of performance based deferred payments payable under the business combination. No definition available.
|
| X | ||||||||||
- Definition Number of technical milestone achievement, the timing of achievement gave raise to change in the estimate under the business combination. No definition available.
|
| X | ||||||||||
- Definition The portion of consideration held back under the business combination arrangement. No definition available.
|
| X | ||||||||||
- Definition Number of component for performance based deferred payments. No definition available.
|
| X | ||||||||||
- Definition Number of technical milestone tranches to be paid as the first component of performance based deferred payments payable under the business combination. No definition available.
|
| X | ||||||||||
- Definition Represents the percentage of holdback payments payable under the business combination. No definition available.
|
| X | ||||||||||
- Definition The amount of compensation cost under the performance based deferred payments as per the business combination arrangements. No definition available.
|
| X | ||||||||||
- Definition Threshold amount of revenue target payments considered as the second component of performance based deferred payments payable under the business combination. No definition available.
|
| X | ||||||||||
- Definition Represents the period after the closing date in which the of holdback payments payable under the business combination. No definition available.
|
| X | ||||||||||
- Definition Period of delay in achievement of technical milestone as a result of change in estimate under the business combination. No definition available.
|
| X | ||||||||||
- Definition Threshold performance based deferred payments payable under the business combination. No definition available.
|
| X | ||||||||||
- Definition Threshold technical milestone payments considered as the first component of performance based deferred payments payable under the business combination. No definition available.
|
| X | ||||||||||
- Definition The cash outflow associated with the payments of closing adjustments on acquisition of a business. No definition available.
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of a business, net of closing adjustments. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The compensation expense recognized during the period pertaining to the deferred compensation arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|